Morphine (Sulfate) Lavoisier (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Morphine (Sulfate) Lavoisier, is an opioid analgesic presented as a sterile solution for epidural, intracerebroventricular and intrathecal use. It provides potent pain relief for severe acute pain and chronic cancer pain in adult patients.

GNH USA supplies Morphine (Sulfate) Lavoisier as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Morphine sulfate is an opioid analgesic indicated for conditions involving severe nociceptive pain. - Severe acute pain: delivers rapid, strong analgesia to control breakthrough pain. - Chronic cancer pain: manages persistent pain associated with malignant disease. - Palliative care pain: provides sustained relief for patients with advanced illness.

Morphine sulfate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel motility. - Drowsiness: increased sleepiness. - Dizziness: sensation of light‑headedness. - Itching: pruritus, often localized. - Urinary retention: difficulty emptying bladder.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing, potentially life‑threatening. - Hypotension: marked drop in blood pressure. - Severe allergic reaction: rash, swelling, anaphylaxis. - Adrenal insufficiency: impaired stress response. - Seizures: rare neurologic events. - Dependence or addiction: risk of misuse with prolonged use.

Morphine sulfate requires careful clinical monitoring to minimize risks. - Assess respiratory function: monitor for depression, especially after dose changes. - Evaluate renal and hepatic function: adjust dosing in impairment. - Avoid concurrent CNS depressants: increased sedation and respiratory risk. - Use caution in elderly patients: heightened sensitivity to effects. - Pregnancy and lactation: weigh benefits against potential fetal or neonatal risks. - Store below 25°C: keep in original container, protect from moisture and light.

Morphine sulfate can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - Benzodiazepines: additive respiratory depression. - MAO inhibitors: risk of severe hypertension or serotonin syndrome. - CYP3A4 inhibitors (e.g., ketoconazole): increased morphine plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): reduced analgesic effect. - Anticholinergic agents: may worsen constipation.